Showing results (151-160 of 499) with videos related to

Sort By:
Pageof 50
AIDS (London, England)|March 7, 2013
MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infectionGuillemette Antoni, Julien Guergnon, Céline Meaudre, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudineConstance Delaugerre, Anne-Geneviève Marcelin, Vincent Thibault, et al.
AIDS (London, England)|June 5, 2007
Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological surveyConstance Delaugerre, Anne-Genevieve Marcelin, Cathia Soulié, et al.
Plos One|May 17, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsJulianna Lisziewicz, Nyasha Bakare, Sandra A Calarota, et al.
Blood|November 15, 2007
Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cellsAmélie Guihot, Eric Oksenhendler, Lionel Galicier, et al.
Journal of Medical Virology|January 15, 2003
Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapyKarine Gourlain, Dominique Salmon, Elyanne Gault, et al.
Annals of the American Thoracic Society|July 28, 2015
Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence CountryAnne Bourgarit, Gabriel Baron, Guillaume Breton, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2015
Combination of two pathways involved in raltegravir resistance confers dolutegravir resistanceIsabelle Malet, Eloise Thierry, Marc Wirden, et al.
Antiviral Therapy|March 23, 2012
Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patientsJean-Philippe Bastard, Cathia Soulié, Soraya Fellahi, et al.
Antiviral Therapy|September 4, 2012
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapyRuxandra Calin, Luc Paris, Anne Simon, et al.
Pageof 50